Immediate Impact

1 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Medications for Obesity
2024 Standout
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2023 Standout
2 intermediate papers

Works of Satu Mäkelä being referenced

Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice
2018
Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies
2017

Author Peers

Author Last Decade Papers Cites
Satu Mäkelä 2025 1011 218 309 112 2.7k
Svetlana F. Khaiboullina 1025 339 26 188 134 2.8k
Qing‐Bin Lu 1768 475 3 382 152 2.8k
Yun Zhang 529 134 19 117 135 2.4k
Minghao Zhou 770 225 13 278 81 1.9k
Xianjun Wang 990 253 331 116 2.4k
Hao Li 1739 413 1 553 86 2.5k
Anna Moniuszko‐Malinowska 944 36 6 240 181 1.8k
Wei Feng 638 149 288 80 3.4k
Aline Rodrigues Hoffmann 299 61 2 165 112 2.4k
Timo U. Kosunen 463 66 3 23 129 5.0k

All Works

Loading papers...

Rankless by CCL
2026